Welcome to a new year with the Flemingsberg Science Foundation

It is with great pleasure that we embark on 2024 with a continued work according to the strategic goals that apply for 2022 – 2025, namely to become the obvious establishment alternative in southern Stockholm, to offer a world-class innovation environment and enable test beds for urban societal challenges.

Based on the results of our operations in 2022 and 2023, we are now entering a new phase where we focus more on the market and marketing of Flemingsberg. We can now offer coworking spaces, a Novum in development, ready-to-build land, and a growing city. Additionally, the initiative ATMP Flemingsberg is being launched, along with a broad-based value proposition. With all these factors in place, it is natural for us to take the next step in promoting Flemingsberg.

For the Flemingsberg Science Foundation, the focus is on “work”. This year is about implementing business development initiatives in research infrastructures, through the investment in the establishment office and with the help of associated partners, solving establishment-inhibiting knots and creating a platform for communication of ATMP Flemingsberg, the leading ATMP hub in the Nordic region! It is also about filling the Innovation Station with the right actors and content that creates tomorrow’s stars in the cultural and creative industries, which will also be an important building block in an emerging, attractive city.

We look forward to continuing our journey together with you and hope that you will follow us during 2024.

Johnny Högberg
CEO, Flemingsberg Science Foundation

Cluster Engine Flemingsberg – ERDF Project for Growth in Life Science

Flemingsberg is taking a significant step towards establishing itself as a central player in Life Science with the launch of the “Cluster Engine Life Science Flemingsberg” project. The project has been granted funding from the European Regional Development Fund and aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. The total project budget is €10.8 million for the years 2025–2027.

BioLamina Establishes Operations in Flemingsberg – A Key Player in ATMP Development

As the world’s first and only producer of laminins, the biotechnology company BioLamina has expanded its operations and chosen to establish part of its business in Flemingsberg. Using laminins, a protein that creates an optimal environment for cells to expand and/or differentiate, they are a key player in the development of ATMPs (Advanced Therapy Medicinal Products) in Sweden and globally.

BIO-Europe – A Conference for Future Medical Innovations

BIO-Europe is Europe’s largest partnering conference for the biotechnology, pharmaceutical, and life science industries. The conference serves as a meeting place where companies, researchers, investors, and other stakeholders in the industry can network, establish collaborations, and discuss business opportunities. The event is held annually in various European cities. This year, BIO-Europe took place in Stockholm from November 4th to 6th, where discussions included advanced cell and gene therapies as the medicine of the future.

Previous 181920 Next